- Rixensart, BE Bartholomew CORSARO - Rockville MD, US David Jeffrey DRIVER - Rockville MD, US Ilse DIEUSSAERT - Rockville MD, US Ouzama HENRY - Rockville MD, US Immaculada MARGARIT-Y-ROS - Siena, IT
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA - Rixensart
International Classification:
A61K 39/09 A61P 31/04
Abstract:
A method of immunising a human female subject to decrease the risk of Group B Streptococcus (GBS) disease in an infant born to the subject, by providing a priming dose of a GBS vaccine and, more than thirty days after the priming dose, providing a boosting dose of a GBS vaccine.
Dr. Driver graduated from the Univ of Sint Eustatius, Sint Eustatius, Netherland Antilles in 2008. He works in Bethesda, MD and specializes in Child & Adolescent Psychiatry and Psychiatry.
Berlin, Conn.Project Manager - System Recruitment at Northeast... Past: Vice President - Business Development at Connecticut Economic Resource Center, President...